Osteoarthritis

Osteoarthritis
#Exogenus Therapeutics #Horizon Europe #Osteoarthritis #Secretome

EU consortium advances secretome-based therapy for osteoarthritis

The ExoCordOA consortium has announced the launch of a five-year, €13 million project, funded by Horizon Europe to advance extracellular vesicle-enriched secretome therapies towards clinical use, with an initial focus on osteoarthritis.  Led by Exogenus Therapeutics, ExoCordOA brings together ten organisations with complementary expertise across biotechnology, clinical… Read More

#Business & Investment #News

Child having ultrasound on knee
#Biopharma #City St George's #Osteoarthritis

City St George’s partners to develop new osteoarthritis drug 

City St George’s is partnering with drug development company Paradigm Biopharmaceuticals to test a drug that could become a new treatment option for osteoarthritis.  The UK-Australian partnership will investigate the effect of injectable pentosan polysulfate sodium (iPPS) – a drug currently being trialled for knee osteoarthritis by Paradigm Biopharmaceuticals… Read More

#News

Osteoarthritis
#Clinical trial #Osteoarthritis

Osteoarthritis treatment could reduce pain by half 

A treatment for osteoarthritis (OA) could slash pain by half and limit stiffness and other debilitating symptoms, a study shows.  LEVI-04, developed by biotechnology company Levicept, is a first-in-class treatment for OA which led to a 50% reduction in pain for patients participating in a Phase II study. Read More

#News

#Breast cancer #Cell therapy #Clinical trial #GLP-1 #Huntington's disease #LoQus23 Therapeutics #Metabolic diseases #Obesity #Osteoarthritis #Ozempic #Phesi #RNAi #Scarcell Therapeutics #Weight loss

DDW Highlights: 13 January 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a new report found breast cancer was the world’s most studied disease… Read More

#Podcasts

#Breast cancer #Cell therapy #Clinical trial #GLP-1 #Huntington's disease #LoQus23 Therapeutics #Metabolic diseases #Obesity #Osteoarthritis #Ozempic #Phesi #RNAi #Scarcell Therapeutics #Weight loss

This week in Drug Discovery (5 – 9 January) 

News round-up for 5 – 9 January by Bruno Quinney, Content Team at DDW.  This week in DDW, a new report finds breast cancer is the world’s most studied disease for the fifth year running. That same report predicts obesity to break into the top five, with weight loss a key theme across… Read More

#News

Knee x-ray
#Cell therapy #Osteoarthritis #Phase I trial #Scarcell Therapeutics

First-ever use of donor gum cells to treat osteoarthritis

Scarcell Therapeutics has treated the first patients with its allogenic gingival fibroblast (aGF) therapy using gum cells from a human donor as part of its Phase Ib clinical trial studying the therapy in knee osteoarthritis (OA).   The first-in-human cases took place at Oxford University Hospitals, UK, and… Read More

#News

#AI #Allergen immunotherapy #Allergy #Alzheimer's #Biotech #China #Clinical trial #DDW Highlights podcast #Eli Lilly #Obesity #Osteoarthritis #Spinogenix

DDW Highlights: 16 December 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, innovative treatments showed potential to treat neurodegenerative diseases, allergies and arthritis. Elsewhere,… Read More

#Podcasts

#AI #Allergen immunotherapy #Allergy #Alzheimer's #Biotech #China #Clinical trial #Eli Lilly #Obesity #Osteoarthritis #Spinogenix

This week in Drug Discovery (8 – 12 December) 

News round-up for 8 – 12 December by Bruno Quinney, Content Team at DDW.  This week in DDW, innovative treatments have been developed for neurodegenerative diseases, allergies and arthritis. Elsewhere, China is becoming the dominant force in the biotech sector.  The top stories:   … Read More

#News

Knee pain
#Arthritis #Osteoarthritis #University of Oxford

Gum cells show potential as cure for knee arthritis 

The world’s first patient has been treated for knee osteoarthritis (OA) using gum cells from a human donor.  The patient was treated at Oxford University Hospitals, UK using Allogenic Gingival Fibroblast (aGF) Therapy, a treatment developed by biotechnology startup Scarcell Therapeutics.  The therapy is designed to prevent… Read More

#News

Child having ultrasound on knee
#Levicept #Osteoarthritis #Phase II trial #University of Leeds

Positive results for neurotrophin-3 inhibitor in osteoarthritis

Phase II trial results for Levicept’s LEVI-04, a novel and first in class neurotrophin-3 (NT-3) inhibitor, have shown that the drug was highly effective and well tolerated. The study enrolled more than 510 participants with pain and disability due to osteoarthritis of the knee. It was… Read More

#News

Knee x-ray
#allogeneic cell therapies #Australia #Cell therapy #Magellan Stem Cells #Osteoarthritis #Stem cells

Donor stem cell therapy delays progression of osteoarthritis

New research by Australian biotechnology company Magellan Stem Cells has demonstrated potential therapeutic benefits of a stem cell therapy for osteoarthritis. The Phase I/II clinical trial assessed the safety and efficacy of MAG200, Magellan Stem Cells’ off-the-shelf allogeneic (donor) stem cell therapy for osteoarthritis of the… Read More

#News

#Cancer research #Dementia #Motor neurone disease #Neuroscience #Osteoarthritis #Schizophrenia

New DDW Highlights episode out now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news highlights this week are mostly focused around neuroscience, with new guiding principles… Read More

#News

#Cancer research #Dementia #Motor neurone disease #Neuroscience #Osteoarthritis #Schizophrenia

This week in drug discovery (4-8 December) 

News round-up for 4-8 December by DDW Digital Content Editor Diana Spencer. The news highlights this week are mostly focused around neuroscience, with new guiding principles and a drug repurposing fund launched for motor neuron disease research, a new drug target found for early-onset dementia, and a… Read More

#News

Child having ultrasound on knee
#Arthritis #Australia #Osteoarthritis #Preclinical investigations #Stem cells #University of Adelaide

Study shows osteoarthritis could be reversible

Osteoarthritis may be treatable and reversible, according to a new University of Adelaide study. The researchers have discovered a novel population of stem cells – marked by the Gremlin 1 gene – responsible for the progression of osteoarthritis. Treatment with fibroblast growth factor 18… Read More

#Editor's Choice #News

Osteoarthritis
#Link Biologics #Osteoarthritis #Preclinical investigations #The University of Manchester

Research reveals promising novel treatment for osteoarthritis

Researchers from the University of Manchester and Link Biologics have revealed preclinical data on a potential new treatment for osteoarthritis. The results were published in a paper in journal Osteoarthritis and Cartilage, which describes the development of a protein biological drug termed Link_TSG6 with disease modifying… Read More

#Editor's Choice #News